HMP Global November 25, 2024

In this interview, Rebecca Maniago, PharmD, discusses the complexities of implementing custom clinical pathways, emphasizing the need for clear goals, robust resources, and ongoing updates, while highlighting the pivotal role of pharmacists in pathway development, regimen management, and enhancing patient outcomes.

Transcript:

Rebecca Maniago, PharmD: My name is Rebecca Maniago. I’m an oncology pharmacist by background, and I’ve worked at Flatiron Health for 5 years now, leading the clinical team that’s involved in the development of our clinical decision support tool called Flatiron Assist. Our application is built on NCCN guidelines; however we allow for local customization, which means I have had the opportunity to work with several customers that have built custom pathways and ultimately integrated those into...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Conferences / Podcast, Pharma, Pharma / Biotech, Trends
CVS, Walgreens & Walmart's healthcare strategy faces headwinds: 10 notes from 2024
FDA says the Zepbound shortage is over. Here’s what that means for compounding pharmacies, patients who used off-brand versions
The CMS NHE 2023 Report: An Incomplete Picture at a Pivotal Time
Mark Cuban's 2025 plans
Pharma At A Crossroads: Navigating Cost Pressures And Regulatory Shifts In 2025

Share This Article